ACE, MTHFR, Factor V Leiden, and APOE Polymorphisms in Patients With Vascular and Alzheimer’s Dementia
- 1 July 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 29 (7), 1401-1404
- https://doi.org/10.1161/01.str.29.7.1401
Abstract
Background and Purpose—There is a growing interest in the use of genetic markers in the differential diagnosis of dementia. In the current study we examined the usefulness of genetic risk factors f...Keywords
This publication has 27 references indexed in Scilit:
- Apolipoprotein E Genotyping and Cerebrospinal Fluid Tau Protein: Implications for the Clinical Diagnosis of Alzheimer’s DiseaseGerontology, 1997
- APOE alleles in Alzheimer's disease and vascular dementia in a population aged 85+Neurobiology of Aging, 1996
- APOE-??4 in Patients with Alzheimer Disease and Vascular DementiaAlzheimer Disease & Associated Disorders, 1996
- Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of ϵ4 allele with AD in Italian octogenarian patientsNeuroscience Letters, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring StudyJournal Of Hypertension, 1993
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.JCI Insight, 1990
- Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial DiseaseNew England Journal of Medicine, 1985
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984